Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCYL1 | O43865 | 3/20 | 0.65 |
| ▸ | AHCY | P23526 | 11/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.47 |
| ▸ | PI4KA | P42356 | 2/20 | 0.47 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.47 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.47 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.47 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.47 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.47 |
| ▸ | GAPDH | P04406 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.47 |
| ▸ | STAT6 | P42226 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17501761 | 1.00 | AHCYL1 (0.65) | AHCYL1AHCYADORA2BPI4KAPI4K2B | |
| SCHEMBL17501744 | 1.00 | AHCYL1 (0.65) | AHCYL1AHCYADORA2BPI4KAPI4K2B | |
| SCHEMBL29361147 | 1.00 | AHCYL1 (0.65) | AHCYL1AHCYADORA2BPI4KAPI4K2B | |
| SCHEMBL17532522 | 0.79 | AHCYL1 (1.00) | AHCYL1AHCYSMN1; SMN2 | |
| SCHEMBL17532524 | 0.79 | AHCYL1 (1.00) | AHCYL1AHCYSMN1; SMN2 | |
| SCHEMBL17532526 | 0.77 | AHCYL1 (1.00) | AHCYL1AHCY | |
| SCHEMBL17532523 | 0.77 | AHCYL1 (1.00) | AHCYL1AHCY | |
| SCHEMBL17501730 | 0.75 | PI4KA (0.53) | AHCYADORA2BPI4KAPI4K2BPI4K2A | |
| SCHEMBL21084885 | 0.75 | PI4KA (0.53) | AHCYADORA2BPI4KAPI4K2BPI4K2A | |
| SCHEMBL17501766 | 0.75 | PI4KA (0.53) | AHCYADORA2BPI4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10787478-B2 | Enantiomers of the 1′,6′-isomer of neplanocin A | AUBURN UNIVERSITY (US) | 2020-09-29 | — | — | US | disclosed |
| US-20190202854-A1 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | AUBURN UNIVERSITY | 2019-07-04 | — | — | US | disclosed |
| US-10227373-B2 | Enantiomers of the 1′,6′-isomer of neplanocin A | AUBURN UNIVERSITY (US) | 2019-03-12 | — | — | US | disclosed |
| US-20170260223-A1 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | AUBURN UNIVERSITY | 2017-09-14 | — | — | US | disclosed |
| US-20170260223-A1 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | AUBURN UNIVERSITY | 2017-09-14 | — | — | US | disclosed |
| US-9657048-B2 | Enantiomers of the 1′,6′-isomer of neplanocin A | AUBURN UNIVERSITY (US) | 2017-05-23 | — | — | US | disclosed |
| US-9657048-B2 | Enantiomers of the 1′,6′-isomer of neplanocin A | AUBURN UNIVERSITY (US) | 2017-05-23 | — | — | US | disclosed |
| WO-2016022563-A1 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | AUBURN UNIVERSITY (US) | 2016-02-11 | — | — | WO | disclosed |
| US-20160039860-A1 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | AUBURN UNIVERSITY | 2016-02-11 | — | — | US | disclosed |
| US-20160039860-A1 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | AUBURN UNIVERSITY | 2016-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10787478-B2 | Enantiomers of the 1′,6′-isomer of neplanocin A | NME2, NTPCR, SAMHD1 | AHCYL1 35/4885AHCY 32/4885ADORA2B 1600/4885 |
| US-10227373-B2 | Enantiomers of the 1′,6′-isomer of neplanocin A | NME2, NTPCR, SAMHD1 | AHCYL1 35/4885AHCY 32/4885ADORA2B 1600/4885 |
| US-20170260223-A1 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | NME2, NTPCR, SAMHD1 | AHCYL1 35/4885AHCY 32/4885ADORA2B 1574/4885 |
| US-20160039860-A1 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | NME2, NTPCR, SAMHD1 | AHCYL1 35/4885AHCY 32/4885ADORA2B 1574/4885 |
| US-20190202854-A1 | ENANTIOMERS OF THE 1',6'-ISOMER OF NEPLANOCIN A | NME2, NTPCR, SAMHD1 | AHCYL1 35/4885AHCY 32/4885ADORA2B 1574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.